老年食管癌的治疗选择

doi:10.3760/cma.j.issn.1004-4221.2018.10.015

Abstract
Figure/Table
References()
Related Citation (15)
Read Tracking
Download Tracking

Download: PDF (0 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS) Supporting Info

Abstract

Along with the intensification of the aging trend, the proportion of elderly patients suffering from esophageal cancer has been ever increased. Radiotherapy plays a pivotal role in the treatment of esophageal cancer in the elderly patients considering their relatively poor tolerance of surgery and high risk of postoperative complications. In this review, the development in the comprehensive treatment of esophageal cancer in the elderly was summarized.

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Wang Xin
	Xiao Zefen

Key words： Esophageal neoplasm/radiotherapy Esophageal neoplasm/chemotherapy Esophageal neoplasm/surgery Elderly patient

Received: 27 October 2017

Fund:

Marathon Hope Fund of Beijing (LC2016L04)

Corresponding Authors: Xiao Zefen,Email: xiaozefen@sina.com

Cite this article:

Wang Xin,Xiao Zefen. Treatment options for esophageal cancer in the elderly patients[J]. Chinese Journal of Radiation Oncology, 2018, 27(10): 941-944.

URL:

http://journal12.magtechjournal.com/Jweb_fszlx/EN/10.3760/cma.j.issn.1004-4221.2018.10.015 OR http://journal12.magtechjournal.com/Jweb_fszlx/EN/Y2018/V27/I10/941

[1] Chen W,Zheng R,Baade PD,et al. Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132.DOI:10.3322/caac.21338.
[2] Wu M,Van′t VP,Zhang ZF,et al. A large proportion of esophageal cancer cases and the incidence difference between regions are attributable to lifestyle risk factors in China[J].Cancer Lett,2011,308(2):189-196.DOI:10.1016/j.canlet.2011.05.003.
[3] Herskovic A,Martz K,al-Sarraf M,et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus[J].N Engl J Med,1992.326(24):1593-1598. DOI:10.1056/NEJM199206113262403.
[4] Cooper JS,Guo MD,Herskovic A,et al. Chemoradiotherapy of locally advanced esophageal cancer:long-term follow-up of a prospective randomized trial (RTOG 85-01)[J].JAMA,1999,281(17):1623-1627.
[5] Wang H,Li G,Chen L,et al. Definitive concurrent chemoradiotherapy with S-1 and cisplatin in elderly esophageal squamous cell carcinoma patients[J].J Thorac Dis,2017,9(3):646-654.DOI:10.21037/jtd.2017.03.105.
[6] Servagi-Vernat S,Créhange G,Roullet B,et al. Phase Ⅱ study of a platinum-based adapted chemotherapy regimen combined with radiotherapy in patients 75 years and older with esophageal cancer[J].Drugs Aging,2015,32(6):487-493.DOI:10.1007/s40266-015-0275-8.
[7] Song T,Zhang X,Fang M,et al. Concurrent chemoradiotherapy using paclitaxel plus cisplatin in the treatment of elderly patients with esophageal cancer[J].Oncol Targ Ther,2015,8:3087-3094.DOI:10.2147/OTT.S92537.
[8] Semrau R,Herzog SL,Vallböhmer D,et al. Radiotherapy in elderly patients with inoperable esophageal cancer. Is there a benefit[J].Strahlenther Onkol,2012.188(3):226-232.DOI:10.1007/s00066-011-0039-2.
[9] Tougeron D,Di FF,Thureau S,et al. Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer[J].Br J Cancer,2008,99(10):1586-1592.DOI:10.1038/sj.bjc.6604749.
[10] Takeuchi S,Ohtsu A,Doi T,et al. A retrospective study of definitive chemoradiotherapy for elderly patients with esophageal cancer[J].Am J Clin Oncol,2007,30(6):607-611.DOI:10.1097/COC.0b013e3180ca7c84.
[11] Markar SR,Karthikesalingam A,Thrumurthy S,et al. Systematic review and pooled analysis assessing the association between elderly age and outcome following surgical resection of esophageal malignancy[J].Dis Esophagus,2013,26(3):250-262.DOI:10.1111/j.1442-2050.2012.01353.x.
[12] Fogh SE,Yu A,Kubicek GJ,et al. Do elderly patients experience increased perioperative or postoperative morbidity or mortality when given neoadjuvant chemoradiation before esophagectomy[J].Int J Radiat Oncol Biol Phys,2011,80(5):1372-1376.DOI:10.1016/j.ijrobp.2010.04.055.
[13] Lester SC,Lin SH,Chuong M,et al. A multi-institutional analysis of trimodality therapy for esophageal cancer in elderly patients[J].Int J Radiat Oncol Biol Phys,2017,98(4):820-828.DOI:10.1016/j.ijrobp.2017.02.021.
[14] Miyata H,Yamasaki M,Makino T,et al. Clinical outcome of esophagectomy in elderly patients with and without neoadjuvant therapy for thoracic esophageal cancer[J].Ann Surg Oncol,2015,22 Suppl 3:794-801.DOI:10.1245/s10434-015-4769-8.
[15] Kodama M,Kakegawa T.Treatment of superficial cancer of the esophagus:a summary of responses to a questionnaire on superficial cancer of the esophagus in Japan[J].Surgery,1998,123(4):432-439.
[16] Hölscher AH,Bollschweiler E,Schröder W,et al. Prognostic impact of upper,middle,and lower third mucosal or submucosal infiltration in early esophageal cancer[J].Ann Surg,2011,254(5):802-807,807-808.DOI:10.1097/SLA.0b013e3182369128.
[17] Molena D,Stem M,Blackford AL,et al. Esophageal cancer treatment is underutilized among elderly patients in the USA[J].J Gastroint Surg,2017,21(1):126-136.DOI:10.1007/s11605-016-3229-5.
[18] Moreno AC,Verma V,Hofstetter WL,et al. Patterns of care and treatment outcomes of elderly patients with stage Ⅰ esophageal cancer:analysis of the national cancer data base[J].J Thorac Oncol,2017,12(7):1152-1160.DOI:10.1016/j.jtho.2017.04.004.
[19] Jing W,Guo H,Kong L,et al. Clinical outcomes of elderly patients (≥70 years) with resectable esophageal squamous cell carcinoma who underwent esophagectomy or chemoradiotherapy:a retrospective analysis from a single cancer institute[J].Medicine (Baltimore),2016,95(50):e5630.DOI:10.1097/MD.0000000000005630.
[20] Smith GL,Smith BD,Buchholz TA,et al. Patterns of care and locoregional treatment outcomes in older esophageal cancer patients:the SEER-Medicare cohort[J].Int J Radiat Oncol Biol Phys,2009,74(2):482-489.DOI:10.1016/j.ijrobp.2008.08.046.
[21] Abrams JA,Buono DL,Strauss J,et al. Esophagectomy compared with chemoradiation for early stage esophageal cancer in the elderly[J].Cancer,2009,115(21):4924-4933.DOI:10.1016/j.ijrobp.2008.08.046.
[22] Xi M,Xu C,Liao Z,et al. The impact of histology on recurrence patterns in esophageal cancer treated with definitive chemoradiotherapy[J].Radiother Oncol,2017,124(2):318-324.DOI:10.1016/j.radonc.2017.06.019.
[23] Kelsen DP,Winter KA,Gunderson LL,et al. Long-term results of RTOG trial 8911(USA Intergroup 113):a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer[J].J Clin Oncol,2007,25(24):3719-3725.DOI:10.1200/JCO.2006.10.4760.
[24] Sjoquist KM,Burmeister BH,Smithers BM,et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma:an updated meta-analysis[J].Lancet Oncol,2011,12(7):681-692.DOI:10.1016/S1470-2045(11)70142-5.
[25] Cohen HJ,Feussner JR,Weinberger M,et al. A controlled trial of inpatient and outpatient geriatric evaluation and management[J].N Engl J Med,2002,346(12):905-912.DOI:10.1056/NEJMsa010285.
[26] Corre R,Greillier L,Le CH,et al. Use of a comprehensive geriatric assessment for the management of elderly patients with advanced non-small-cell lung cancer:the phase Ⅲ randomized ESOGIA-GFPC-GECP 08-02 study[J].J Clin Oncol,2016,34(13):1476-1483.DOI:10.1200/JCO.2015.63.5839.
[27] Caillet P,Canoui-Poitrine F,Vouriot J,et al. Comprehensive geriatric assessment in the decision-making process in elderly patients with cancer:ELCAPA study[J].J Clin Oncol,2011,29(27):3636-3642.DOI:10.1200/JCO.2010.31.0664.
[28] Bedenne L,Michel P,Bouché O,et al. Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus:FFCD 9102[J].J Clin Oncol,2007,25(10):1160-8116.DOI:10.1200/JCO.2005.04.7118.
[29] Zhang W,Zhu H,Liu X,et al. Epidermal growth factor receptor is a prognosis predictor in patients with esophageal squamous cell carcinoma[J].Ann Thorac Surg,2014,98(2):513-519.DOI:10.1016/j.athoracsur.2014.03.015.
[30] Guo YM,Yu WW,Zhu M,et al. Clinicopathological and prognostic significance of epidermal growth factor receptor overexpression in patients with esophageal adenocarcinoma:a meta-analysis[J].Dis Esophagus,2015,28(8):750-756.DOI:10.1111/dote.12248.
[31] Ramos-Suzarte M,Lorenzo-Luaces P,Lazo NG,et al. Treatment of malignant,non-resectable,epithelial origin esophageal tumours with the humanized anti-epidermal growth factor antibody nimotuzumab combined with radiation therapy and chemotherapy[J].Cancer Biol Ther,2012,13(8):600-605.DOI:10.4161/cbt.19849.
[32] Liang J,E M,Wu G,et al. Nimotuzumab combined with radiotherapy for esophageal cancer:preliminary study of a Phase Ⅱ clinical trial[J].Onco Targets Ther,2013,6:1589-1596.DOI:10.2147/OTT.S50945.
[33] Lin SH,Zhang N,Godby J,et al. Radiation modality use and cardiopulmonary mortality risk in elderly patients with esophageal cancer[J].Cancer,2016,122(6):917-928.DOI:10.1002/cncr.29857.